Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
South Med J. 2003 Jul;96(7):699-701.

Orally disintegrating olanzapine for the treatment of psychotic and behavioral disturbances associated with dementia.

Author information

  • 1Department of Psychiatry, University of Mississippi School of Medicine, Jackson, MS, USA. roy.reeves@med.va.gov

Abstract

Orally disintegrating olanzapine is a recently marketed form of olanzapine that dissolves rapidly on contact with saliva. We describe six demented patients resistant to treatment with common oral antipsychotic medications who were successfully treated with the formulation. The importance of these case reports is to make physicians aware that orally disintegrating olanzapine may be useful for the management of psychobehavioral disturbances in demented patients who resist or have difficulty taking standard oral medications.

PMID:
12940325
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Southern Medical Association
    Loading ...
    Write to the Help Desk